GARY A LYONS Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for GARY A LYONS.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of GARY A LYONS. GARY A LYONS is a in Brickell Biotech, Inc. ($VICL) and a Director in VICAL INC ($VICL) and a Director in NEUROCRINE BIOSCIENCES INC ($NBIX) and a Director in Ardea Biosciences, Inc./DE ($IBPI) and a Director in RIGEL PHARMACEUTICALS INC ($RIGL) and a Director in CYTORI THERAPEUTICS, INC. ($XMP) and a Director in KALOBIOS PHARMACEUTICALS INC ($KBIO) and a Director in Novus Therapeutics, Inc. ($TKAI) and a Director in Retrophin, Inc. ($RTRX).

Address: 2483 E. BAYSHORE RD, SUITE 100 PALO ALTO 94303 CA

Companies in which GARY A LYONS is an Insider

Ardea Biosciences, Inc./DE

Trading Symbol: IBPI
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of GARY A LYONS: Director
Holdings: 0 shares
Latest Transaction: Apr 15 2005

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Brickell Biotech, Inc.

Trading Symbol: VICL
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of GARY A LYONS: Director
Holdings: 24,729 shares
Current Value: $52,673
Latest Transaction: Sep 17 2020
$VICL Market Capitalization: $24.86M
$VICL Previous Close: $2.13

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Eledon Pharmaceuticals, Inc.

Trading Symbol: ELDN
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of GARY A LYONS: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Sep 15 2020
$ELDN Market Capitalization: $20.25M
$ELDN Previous Close: $0.91

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

HUMANIGEN, INC

Trading Symbol: KBIO
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of GARY A LYONS: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jul 14 2015
$KBIO Market Capitalization: $44.71M
$KBIO Previous Close: $2.89

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

NEUROCRINE BIOSCIENCES INC

Trading Symbol: NBIX
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of GARY A LYONS: Director
Holdings: 224,097 shares
Current Value: $9,770,629
Latest Transaction: Jan 27 2021
$NBIX Market Capitalization: $3.81B
$NBIX Previous Close: $43.60

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

PLUS THERAPEUTICS, INC.

Trading Symbol: PSTV
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of GARY A LYONS: Director
Holdings: 4,358 shares
Latest Transaction: Jan 27 2017

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

RIGEL PHARMACEUTICALS INC

Trading Symbol: RIGL
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of GARY A LYONS: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: May 15 2020
$RIGL Market Capitalization: $237.45M
$RIGL Previous Close: $2.45

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Travere Therapeutics, Inc.

Trading Symbol: RTRX
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of GARY A LYONS: Director
Holdings: 37,000 shares
Current Value: $742,590
Latest Transaction: May 18 2021
$RTRX Market Capitalization: $766.34M
$RTRX Previous Close: $20.07

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Latest Insider Trading Transactions of GARY A LYONS

Sentiment: All, IBPI, VICL, ELDN, KBIO, NBIX, PSTV, RIGL, RTRX

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
May 18 2021	RTRX	Travere Therapeuti ...	LYONS GARY A	Director	Option Exercise	A	18.27	9,000	164,430	9,000
May 18 2021	RTRX	Travere Therapeuti ...	LYONS GARY A	Director	Grant	A	0.00	3,000	0	37,000	34 K to 37 K (+8.82 %)
Jan 27 2021	NBIX	NEUROCRINE BIOSCIE ...	LYONS GARY A	Director	Sell	S	120.00	400	48,000	223,697	224.1 K to 223.7 K (-0.18 %)
Jan 27 2021	NBIX	NEUROCRINE BIOSCIE ...	LYONS GARY A	Director	Sell	S	120.03	1,600	192,047	224,097	225.7 K to 224.1 K (-0.71 %)
Sep 17 2020	VICL	Brickell Biotech, ...	LYONS GARY A	Director	Option Exercise	A	0.80	60,000	48,000	60,000
Sep 17 2020	VICL	Brickell Biotech, ...	LYONS GARY A	Director	Grant	A	0.81	11,934	9,667	24,729	12.8 K to 24.7 K (+93.27 %)
Sep 15 2020	NVUS	Novus Therapeutics ...	LYONS GARY A	Director	Option Exercise	A	500.00	1,167	583,500	1,167

View all GARY A LYONS insider transactions.